Dx dialogues: blood-based biomarkers and other diagnostic tools for Alzheimer's and related dementias
Monica Parker, MD, discusses blood-based biomarkers and their uses in the diagnosis of Alzheimer's disease.
Up Next
Dx dialogues: overlapping symptomatology of Alzheimer's and other neurodegenerative disorders
Dx dialogues: disease-modifying therapies for Alzheimer's and the hope for a cure
Dx dialogues: considerations when deciding whether to initiate pharmacologic interventions for patients with AD
Dx dialogues: novel approaches in development for the treatment of AD
How lipid and glucose levels are associated with Alzheimer's disease
Dx dialogues: how AI can be integrated in the management of AD
Why I care: why Dr. Heather Snyder is driven to educate others
What do you know about dementia and Alzheimer's disease that you didn't know before?
Are we spending enough on Alzheimer's research?
How is Alzheimer's disease different from memory loss due to aging?
